Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
Five-year agreement will support selected Gilead technology programs TEANECK, N.J., Oct. 6, 2026 /PRNewswire/ -- Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than...
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Résiliable à tout moment · 99 $ CA/mois


